Key result
Hydrocortisone therapy in central adrenal insufficiency restores LVEF to 55% and resolves severe valvular regurgitation.
Why the study?
Adrenal insufficiency can cause serious cardiovascular complications such as reversible cardiomyopathy, but awareness of this etiology remains limited.
Case Report (n=1)
No
Adrenal insufficiency is a potential cause of unexplained cardiomyopathy that can be reversed with appropriate endocrine therapy.
May support reversible cardiomyopathy with hydrocortisone in central adrenal insufficiency; hypothesis-generating and should not yet change practice.
Adrenal insufficiency, though rare, can cause serious cardiovascular complications such as reversible cardiomyopathy. We present the case of a 56-year-old woman admitted to the intensive care unit with bradycardia, hypotension, and hypoglycemia, followed by hemodynamic instability and subsequent development of supraventricular tachycardia requiring stabilization. Endocrine assessment performed after stabilization demonstrated panhypopituitarism with radiological evidence of an empty sella, central hypothyroidism, and biochemical findings consistent with central adrenal insufficiency, confirmed by low morning cortisol with low adrenocorticotropic hormone levels. On admission, echocardiography showed biventricular dysfunction with a reduced ejection fraction and severe tricuspid regurgitation. Following initiation of intravenous hydrocortisone and supportive therapy, repeat echocardiography at one month demonstrated significant improvement, with recovery of systolic function and marked reduction in valvular regurgitation, consistent with reversible cardiomyopathy. This case highlights the importance of adrenal insufficiency as a potential cause of unexplained cardiomyopathy. The patient's cardiac function improved markedly following appropriate endocrine therapy, with normalization of ejection fraction and resolution of valvular abnormalities. These findings underscore the value of early endocrine evaluation and timely management in preventing irreversible cardiac damage and achieving complete functional recovery.
No takes yet. Share an insight, caveat, or question.
Makki et al. (2026) conducted a case report in Reversible cardiomyopathy induced by adrenal insufficiency (n=1). Hydrocortisone was evaluated on Left ventricular ejection fraction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: